PCD Foundation hosted a live webinar entitled:
A New Clinical Trials for DNAI1 PCD.

Learn about an upcoming clinical trial of an mRNA therapy developed by ReCode Therapeutics that will target PCD-causing genetic defects in the DNAI1 gene.

Presented by  Ramona Doyle, MD.
Clinical Professor of Medicine, UCSF
Consultant, ReCode Therapeutics